Skip to content
Clinical Trials – home

Academisch Ziekenhuis Maastricht

Verifiedinfo

The Netherlands P. O. Box 616, 6200 MD Maastricht, The Netherlands

  • 6 trials recruiting
  • Prostate cancer metastatic · Non-small cell lung cancer metastatic · Small cell lung cancer extensive stage
  • Adults and children

About Specializations

Academisch Ziekenhuis Maastricht in Maastricht, The Netherlands specialises in clinical trials of conditions such as Prostate cancer metastatic, Non-small cell lung cancer metastatic, Small cell lung cancer extensive stage, Transitional cell carcinoma, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, focusing on innovative treatments for various types of cancer. The center's work in this field is driven by a commitment to improving patient outcomes through cutting-edge therapies and personalized medicine.

  • Non-Small Cell Lung Cancer
  • Gastroenteropancreatic Neuroendocrine Tumors
  • Endometrial Cancer
  • Cervical Cancer
  • Prostate Cancer

By integrating clinical trials with translational research, the center is advancing the understanding of cancer biology and developing new therapeutic strategies.

Cardiology

Specializing in cardiology, the center is dedicated to pioneering research in cardiovascular diseases. The focus is on developing novel interventions and improving existing treatments to enhance patient care and outcomes.

  • Acute Heart Attack
  • Aortic Stenosis
  • Genetic Dilated Cardiomyopathy

The center's research efforts are aimed at understanding the underlying mechanisms of heart diseases and translating these findings into effective clinical applications.

Hematology

The center is a leader in hematology research, focusing on blood disorders and hematologic malignancies. The research conducted here is instrumental in developing new therapies and improving patient management strategies.

  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma

Through collaborative efforts and clinical trials, the center is advancing the treatment landscape for hematologic conditions, offering hope to patients worldwide.

Nephrology

In the field of nephrology, the center is committed to advancing research on kidney diseases. The focus is on innovative treatments and improving the quality of life for patients with renal conditions.

  • Acute Kidney Injury
  • Lupus Nephritis
  • IgA Nephropathy

The center's research initiatives are aimed at understanding the pathophysiology of kidney diseases and developing targeted therapies to address these challenges.

Immunology

Focusing on immunology, the center is dedicated to exploring the immune system's role in health and disease. The research conducted here is pivotal in developing new immunotherapies and enhancing existing treatment protocols.

  • Primary Immunodeficiency Diseases
  • Psoriatic Arthritis
  • Autoimmune Disorders

By leveraging cutting-edge technologies and collaborative research, the center is making significant strides in understanding and treating immune-related conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
P. O. Box 6166200 MD MaastrichtThe Netherlands
Recruiting now
6 trials
Conditions studied
28
Partner status
Verified

More sites in MaastrichtThe Netherlands

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

24 clinical trials

Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Tarlatamab
  • Sponsor:Academisch Ziekenhuis Maastricht
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:AstraZeneca AB
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Acenocoumarol
  • Sponsor:St Antonius Hospital
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Academisch Ziekenhuis Maastricht
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Argipressin
  • Sponsor:Amgen Inc.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Amgen Inc.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Naronapride Dihydrochloride Trihydrate
  • Sponsor:Dr. Falk Pharma GmbH
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Gilteritinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Myotonic dystrophy

Not recruiting
Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years
  • Substances:Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dmpk Via A Non-Cleavable Linker
  • Sponsor:Avidity Biosciences Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.